loobobilly News: Obesity Drug's Promise Now Hinges On Insurance Coverage

Obesity Drug's Promise Now Hinges On Insurance Coverage Clinical trials show Wegovy triples the average weight loss seen with other drugs. Whether it will reach many patients largely depends on whether insurers decide to cover it. Clinical trials show Wegovy triples the average weight loss seen with other drugs. Whether it will reach many patients largely depends on whether insurers decide to cover it. Business
Clinical trials show Wegovy triples the average weight loss seen with other drugs. Whether it will reach many patients largely depends on whether insurers decide to cover it.

Read more on NPR